T +1 212 819 7019
Patti Marks is a counsel in the Mergers & Acquisition Group. Her practice includes corporate finance, securities and mergers and acquisitions matters. Ms. Marks has extensive experience representing both issuers and underwriters in public and private debt and equity offerings. Ms. Marks also has extensive experience structuring and advising investment banks and issuers on liability management transactions, focusing on corporate debt restructurings involving issuer buy-backs of outstanding debt securities and consent solicitations. In addition, Ms. Marks regularly advises corporate and investment banking clients in connection with mergers and acquisitions and general corporate and securities laws matters.
Omnicare, Inc. in its offering of US$500 million 3.75% convertible senior subordinated notes due 2025.
Barclays Capital and Goldman Sachs in connection with Dine Equity, Inc.'s private offering of US$825 million 9.5% senior notes due 2018 and in related tender offers and consent solicitations, in connection with a US$1.6 billion refinancing by Dine Equity.
LifePoint Hospitals, Inc. in its offering of US$400 million 6.625% senior notes due 2020, the company's inaugural high-yield notes offering.
Johnson & Johnson in its US$1.1 billion dual-tranche senior notes offering, comprising US$550 million 2.95% notes due 2020 and US$550 million 4.50% notes due 2040.
Central European Distribution Corporation in concurrent equity and senior secured high-yield notes offerings, aggregating US$1.2 billion in proceeds, comprising 10.25 million shares of common stock, US$380 million 9.125% senior secured notes due 2016 and €380 million 8.875% senior secured notes due 2016, to finance, among other things, the acquisition of the Russian Alcohol Group.